What is the recommended dose of nystatin (antifungal medication) for oral thrush in a 7-month-old infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 7-month-old infant with oral thrush, the recommended nystatin dose is 4–6 mL of oral suspension at a concentration of 100,000 U/mL, administered 4 times daily, as stated in the clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of america 1.

Key Considerations

  • The treatment should be continued for 7–14 days, as recommended by the guidelines 1.
  • The medication should be applied using a clean finger or cotton swab, coating the affected areas inside the cheeks, gums, and tongue.
  • It is essential to shake the bottle well before each use and not rinse the baby's mouth afterward to maximize contact time with the affected tissues.
  • Nystatin works by binding to ergosterol in the fungal cell membrane, creating pores that lead to cell death of the Candida yeast causing the infection.
  • If symptoms don't improve within 3-5 days, or if the infant has difficulty feeding or appears in pain, it is crucial to consult a pediatrician as an alternative treatment may be needed.

Additional Recommendations

  • Good hygiene practices, including sterilizing pacifiers and bottle nipples, can help prevent reinfection.
  • The guidelines also recommend fluconazole as an alternative treatment option for moderate to severe disease, at a dosage of 100–200 mg (3 mg/kg) daily for 7–14 days 1.
  • However, for a 7-month-old infant, nystatin suspension is a more suitable option, as it is specifically recommended for mild disease and is easier to administer in infants 1.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION Infants: 2 mL (200,000 units) four times daily (in infants and young children, use dropper to place one-half of dose in each side of mouth and avoid feeding for 5 to 10 minutes).

  • The recommended dose of nystatin for oral thrush in a 7-month-old infant is 2 mL (200,000 units) four times daily.
  • It is advised to use a dropper to place one-half of the dose in each side of the mouth and avoid feeding for 5 to 10 minutes 2.

From the Research

Nystatin Dosage for Oral Thrush in Infants

  • The recommended dose of nystatin for oral thrush in infants is not explicitly stated in the provided studies, but the dosage used in the studies can be referenced.
  • In the study 3, nystatin oral suspension was administered four times a day for 10 days.
  • In the study 4, oral nystatin was administered three times a day, but the duration of treatment and dosage are not specified.
  • In the study 5, two commercial oral nystatin gels were used, with treatment durations of 10 days and 14 days, but the exact dosage is not provided.
  • In the study 6, nystatin was administered at a dose of 400,000 units four times daily for 14 days.
  • In the study 7, nystatin suspension was administered at a dose of 100,000 IU four times daily after meals, but the exact duration of treatment is not specified.

Efficacy of Nystatin in Treating Oral Thrush

  • The efficacy of nystatin in treating oral thrush in infants varies across the studies, with clinical cure rates ranging from 21.2% to 51% 3, 6, 7.
  • In comparison, other antifungal medications such as fluconazole and miconazole have shown higher clinical cure rates in treating oral thrush in infants 3, 6, 7.

Administration and Safety

  • Nystatin is generally well-tolerated in infants, with few reported side effects 6, 7.
  • However, the administration of nystatin can be challenging, particularly in young infants, due to the frequency of dosing and the potential for difficulty in swallowing the suspension 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.